Molecular genetic determinants of arterial thrombosis in patients with thoracoabdominal malignant tumors

نویسندگان

چکیده

Background . Acute ischemic cerebral circulation disorder and myocardial infarction occupy one of the first places among causes postoperative mortality in patients with malignant tumors thoracoabdominal localization. The issue role molecular genetic factors cardiovascular risk development these complications has not been resolved at present. Objective To analyze effect polymorphisms hemostasis system genes on coronary artery thrombosis Materials methods study included 163 operated Oncological Department Surgical Methods Treatment No. 11 (Thoracic Oncology) N.N. Blokhin National Medical Research Center Oncology 2018-2019. Two groups consisted (n = 62) stroke 24) perioperative period or anamnesis. data a history both 4) were taken into account groups. control group 81) who had no severe concomitant pathology, including family history. A to determine was performed Laboratory Clinical Oncogenetics using reagents “Cardiogenetics Thrombophilia” (DNA Technology LLC, Russia; RU FSR 2010/08414 dated 11/22/2016). Results In localization have suffered infarction, comparison without statistically significant difference frequency carriage homozygous variants FGB (χ 2 8.18, p 0.005), ITGA2 9.48, 0.003), PAI-1 4.45, 0.035), heterozygous forms F5 4.0, 0.046), 14.72, <0.001), ITGB3 4.28, 0.039), as well total aberrations genes. an stroke, determined relative variant mutation F2 gene 6.881, 0.009), form 15.724, 3.861, 0.05), carrying mutations did obtain studied respect polymorphism carriers G/A F7 (coagulation factor VII) G/T F13 XIII) associated reduced thrombotic conditions. all 91.7 % cases, several procoagulant noted genotype stroke; diseases, this indicator 53 %, 39.61, <0.001; χ 11.685, <0.001, respectively). Conclusion Based results high thrombogenic risk, occurrence polymorphic markers G1691A, G(-455)A, C807T, T1565C, 4G(-675)5G revealed G20210A, T1565C compared cancer pathology. conducted make it possible identify oncological increased developing take additional measures prevent complications.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Genetic determinants of arterial thrombosis.

Arterial thrombosis is a complex disorder that involves multiple genetic and environmental factors interacting to produce the characteristic phenotype. In the past decades, investigators have focused on the molecular genetics of arterial vascular disorders and have identified numerous polymorphisms and mutations in genes related to the hemostatic system and to enzymes involved in the synthesis ...

متن کامل

A Rare Presentation of Arterial Thrombosis after Venous Thrombosis in a Patient with Gastric Cancer

Background: Venous thromboembolism, which comprises deep vein thrombosis and pulmonary embolism and is a significant cause of morbidity and mortality among patients with cancer. The aim of the present study was to report a rare presentation of arterial thrombosis after venous thrombosis in a patient with gastric cancer. Report of the Case: A 45 year-old female patient with locally advanced gas...

متن کامل

Main Determinants of Severe Neutropenia in Patients with Solid Tumors Receiving Adjuvant Chemotherapy

Background:Chemotherapy-induced neutropenia as a major toxicity of systemic chemotherapy is commonly associated with substantial mortality and morbidity, and thus identifying its determinants is necessary. This study was undertaken to identify main risk factors of severe neutropenia following adjuvant chemotherapy treatment in a community-based population of patients with cancer in Semnan, I...

متن کامل

Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors

Introduction: Cyfra 21 is a serum-soluble fragment of cytokeratin19. Increased Cyfra 21 serum levels and their benefit as a tumor marker have been shown in some malignancies. This study aimed to evaluate the serum levels of Cyfra 21 in patients with benign and malignant salivary gland tumors. Materials and Methods: In this cross-sectional study, the serum level of Cyfra 21 in 44 patients with m...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: MD-onco

سال: 2022

ISSN: ['2782-3202']

DOI: https://doi.org/10.17650/2782-3202-2022-2-4-46-55